ProfessorDepartment of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.Nagoya, Aichi, Japan
OC 59.3 - Pooled Safety Results from the Multidose explorer Studies of Concizumab in Patients with Haemophilia
Tuesday, June 27, 202315:15 – 15:30 ET
OC 59.4 - Health-related quality of life, treatment burden and patient preference in patients with haemophilia A/B without inhibitors on concizumab prophylaxis: results from the phase 3 explorer8 study
Tuesday, June 27, 202315:30 – 15:45 ET
PB1263 - Third Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol in Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World HEM-POWR Study
Tuesday, June 27, 202318:30 – 19:30 ET
